🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a study of two treatment pathways \[Standard steroid treatment vers...
Status
Completed
Location
University Hospital Bristol NHS Foundation Trust
Start Date
2017-10-25
Trial ID
NCT03156452
Treatments Being Tested
The goal of this clinical trial is to assess whether the early introduction...
Status
Recruiting
Location
Department of Oncology, Aalborg University Hospital
Start Date
2023-08-22
Trial ID
NCT05947669
Treatments Being Tested
ASIT naïve patients sensitized to grass pollens will be recruited for the s...
Status
Unknown
Location
Medical University Sofia, University Hospital "Alexandrovska", Clinic of Allergy and Asthma
Start Date
2015-05
Trial ID
NCT02557269
Belatacept is an experimental medication shown in clinical trials to have i...
Status
Terminated
Location
University of California, San Francisco
Start Date
2006-12
Trial ID
NCT00346151
Treatments Being Tested
This study consists of two periods. The objective of Period 1 is to evaluat...
Status
Completed
Location
Rheum Assoc of North Alabama /ID# 168668
Start Date
2019-01-24
Trial ID
NCT03725202
Treatments Being Tested
This study will assess the efficacy and safety of capivasertib plus abirate...
Status
Active Not Recruiting
Location
Research Site
Start Date
2020-07-13
Trial ID
NCT04493853
Treatments Being Tested
This study will investigate the efficacy and safety of a steroid avoidance ...
Status
Completed
Location
C.H.U. La Milétrie
Start Date
2007-04
Trial ID
NCT00413920
Treatments Being Tested
A study to determine whether a new formulation of methylprednisolone suspen...
Status
Withdrawn
Location
Multiple Locations
Start Date
2012-01-01
Trial ID
NCT01405131
Treatments Being Tested
This study will assess whether a calcineurin inhibitor (CNI)-free regimen w...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-02-24
Trial ID
NCT00862979
Primary Objective: To evaluate the effect of caplacizumab on prevention of...
Status
Completed
Location
Investigational Site Number 3920009
Start Date
2019-10-21
Trial ID
NCT04074187